QRxPharma Ltd (OTCQX International:QRXPY.PK)

0.0301
Delayed Data
As of May 22
 -0.0091 / -23.21%
Today’s Change
0.03
Today|||52-Week Range
0.49
-62.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$988.4K

Company Description

QRxPharma Ltd. is a commercial-stage specialty pharmaceutical company. It is focused on the development and commercialization of new treatments for pain management and central nervous system disorders. The company's product portfolio includes MoxDuo IR, MoxDuo IV and MoxDuo CR. QRxPharma was founded by Pace W. Gary, Michael A Quinn and Felix de la Iglesia on Setember 19, 2002 and is headquartered in Sydney, Australia.

Contact Information

QRxPharma Ltd.
100 Walker Street
North Sydney New South Wales (nsw) 2060
P:(128) 404-4139
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Edward M. RudnicChief Executive Officer
Chris J. CampbellChief Financial Officer & Secretary
M. Janette DixonSenior Vice President-Global Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account